ZTOX

Gautam Exim Board Meeting Concludes: FY2026 Audited Results Filed

Gautam Exim Limited has concluded its adjourned board meeting on May 28, 2026, disclosing audited standalone financial results for the half year and year ended March 31, 2026, as per SEBI LODR regulations.

Gautam Exim Board Meets May 28, Concludes FY2026 Review

Gautam Exim Limited's board of directors concluded an adjourned meeting on May 28, 2026, approving standalone financial results for the half year and fiscal year ending March 31, 2026, with statutory auditors issuing an unmodified opinion.

Gautam Exim Board Concludes FY2026 Review; Unmodified Audit Opinion Confirmed

Gautam Exim Limited's adjourned board meeting concluded on May 28, 2026, with the board approving audited standalone financial results for the half year and year ended March 31, 2026.

Gautam Exim Board Meeting Concludes with FY2026 Financial Results

Gautam Exim Limited's board meeting on May 28, 2026 concluded with approval of standalone audited financial results for the half year and year ended March 31, 2026, accompanied by an unmodified audit opinion.

SERVOTECH

SERVOTECH Stock Draws Attention on Unusual Trading Volume

Servotech Renewable Power System (SERVOTECH) stock is drawing attention as unusual trading volume of 3.39 million shares moves the price marginally to ₹112.30.

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY2026

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for FY2026, subject to approval at the upcoming Annual General Meeting.

Lincoln Pharmaceuticals Recommends ₹1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for FY26, representing an 18% return on the Rs 10 face value.

NAHARCAP

Nahar Capital Declares Rs 1.50 Final Dividend for FY26

Nahar Capital and Financial Services recommends Rs 1.50 final dividend per equity share for FY26. Board meeting held May 28, 2026.

Lincoln Pharmaceuticals Proposes Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has proposed a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026, awaiting shareholder approval at the ensuing AGM.

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026.

NAHARSPING

Nahar Spinning Mills Announces Q4 FY2026 Financial Results

Nahar Spinning Mills Limited has disclosed its financial results for the period ended March 31, 2026, following a board meeting outcome submitted to the NSE.

NAHARSPING

Nahar Spinning Mills Files FY2026 Results: Board Meeting Outcome

Nahar Spinning Mills Limited (NAHARSPING) has submitted its financial results for the period ended March 31, 2026 to the NSE following a board meeting.

NAHARSPING